Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.

Breeksema, Joost J; Kuin, Bouwe W; Kamphuis, Jeanine; van den Brink, Wim; Vermetten, Eric; Schoevers, Robert A

Breeksema, Joost J; Kuin, Bouwe W; Kamphuis, Jeanine; van den Brink, Wim; Vermetten, Eric; Schoevers, Robert A.

Afiliación

Breeksema JJ; Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Kuin BW; Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands.
Kamphuis J; OPEN Foundation, Amsterdam, The Netherlands.
van den Brink W; Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Vermetten E; Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Schoevers RA; Department of Psychiatry, Amsterdam University Medical Center, Amsterdam, The Netherlands.

J Psychopharmacol ; 36(10): 1100-1117, 2022 10.

Article en En | MEDLINE | ID: mdl-36017784

Asunto(s)

Banisteriopsis; Alucinógenos; N-Metil-3,4-metilenodioxianfetamina; Cefalea/inducido químicamente; Humanos; Dietilamida del Ácido Lisérgico; N-Metil-3,4-metilenodioxianfetamina/efectos adversos; Psilocibina/uso terapéutico

Palabras clave

LSD; MDMA; Psychedelics; adverse effects; adverse events; ayahuasca; psilocybin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: N-Metil-3,4-metilenodioxianfetamina / Banisteriopsis / Alucinógenos Tipo de estudio: Prognostic_studies / Qualitative_research / Systematic_reviews Límite: Humans Idioma: En Revista: J Psychopharmacol Asunto de la revista: PSICOFARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google